EssilorLuxottica stock (FR0000121667): focus on scrip dividend settlement as new shares prepare to list in Paris
02.06.2026 - 20:34:31 | ad-hoc-news.de
EssilorLuxottica shares on Euronext Paris were recently quoted in the mid-EUR 170 range as investors in France digest the final steps of the 2025 dividend payment, which offered a choice between cash and scrip, according to pricing data from Boursorama as of 05/31/2026 and exchange data from Euronext Paris.
The optical group had confirmed on its investor relations site on 05/24/2026 that the issue price of new ordinary shares under the scrip dividend option was set at EUR 175.06 per share, equal to 90% of the average opening prices of the stock on Euronext Paris over the 20 trading sessions before the annual shareholders meeting that approved the payout, with the company reiterating that the new shares would carry the same rights as existing ones.
In a subsequent press release on 06/01/2026, EssilorLuxottica detailed the outcome of the dividend choice and the related capital increase, stating that settlement and delivery of the new shares as well as their admission to trading on Euronext Paris are scheduled for 06/03/2026, according to a company announcement available on its investor relations page and mirrored on Business Wire.
The stock traded at around the mid-EUR 170 range on 05/31/2026 on Euronext Paris, according to Euronext data as cited by Boursorama, while the French group remains a constituent of the CAC 40 index, underscoring its role in the home market and its visibility for domestic equity investors.
As of: 06/02/2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: EssilorLuxottica
- Sector/industry: Eyewear, lenses and vision care
- Headquarters/country: Paris, France
- Core markets: Europe, North America, Asia-Pacific and Latin America
- Key revenue drivers: Prescription lenses, optical frames, sunglasses and optical retail chains
- Home exchange/listing venue: Euronext Paris (EL)
- Trading currency: EUR
EssilorLuxottica: core business model
EssilorLuxottica operates as an integrated global eyewear and vision-care group, combining lens technologies, frame manufacturing and branded optical retail networks to generate revenue across prescription products and sunglasses sold through wholesale and owned stores.
Latest quarterly results for EssilorLuxottica at a glance
In its most recent quarterly report for the first quarter of 2026, released on 04/25/2026, EssilorLuxottica reported consolidated revenue growth versus the prior-year period, with the company highlighting continued momentum in its retail and lens activities, according to a summary of the Q1 2026 figures on its investor relations site and a related overview on ad-hoc-news.de.
The group noted in the same 04/25/2026 communication that North America and Europe remained key contributors to sales, with performance supported by demand for branded eyewear and innovative lens offerings, while management reiterated its focus on executing its long-term strategy without providing quantified full-year guidance for 2026.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on EssilorLuxottica
The latest dividend settlement and upcoming listing of new shares may shape how market participants discuss EssilorLuxottica on social and video platforms, especially around dilution, yield and long-term growth prospects.
Conclusion
The near-term focus for EssilorLuxottica investors in France centers on the technical completion of the 2025 dividend in shares, with new stock set to start trading on Euronext Paris after the settlement date and the share price stabilizing around the mid-EUR 170 range before the admission of the additional shares.
At the same time, the Q1 2026 update from 04/25/2026 shows that the company continues to lean on its global retail footprint and lens innovation to drive revenue, suggesting that the dividend-related capital increase is part of a broader capital allocation framework rather than a shift in strategic direction.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
